Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
Open-market buys, last 90 days
$391,200
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$391,200. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Todisco Joseph +$391K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-14 Costa Paulo F Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-11-15 Todisco Joseph Chief Executive Officer Purchase +20,000 $3.82 $76K 242,169
2022-08-24 Todisco Joseph Chief Executive Officer Purchase +4,700 $3.92 $18K 222,169
2022-05-17 Kaplan Myron Director Purchase +5,000 $3.78 $19K 160,034
2022-05-16 Todisco Joseph Chief Executive Officer Purchase +10,000 $3.38 $34K 217,469
2022-05-10 Todisco Joseph Chief Executive Officer Grant or award +207,469 207,469
2022-05-10 Todisco Joseph Chief Executive Officer Grant or award · Stock Option (Right to Buy Common Stock) +500,000 500,000
2022-02-22 Costa Paulo F Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-02-22 Duncan Gregory Scott Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-02-22 DUNTON ALAN W Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-02-22 Lefkowitz Steven W Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-02-22 Kaplan Myron Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-02-22 Dillione Janet Director Grant or award · Stock Option (Right to Buy Common Stock) +20,000 20,000
2022-02-18 Nusbickel Thomas EVP, Chief Commercial Officer Grant or award · Stock Option (Right to Buy Common Stock) +100,000 100,000
2022-02-18 Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. Grant or award · Stock Option (Right to Buy Common Stock) +100,000 100,000
2022-02-18 Mounts Phoebe General Counsel Grant or award · Stock Option (Right to Buy) +140,000 140,000
2022-02-18 David Matthew T Interim CEO and CFO Grant or award · Stock Option (Right to Buy Common Stock) +0 100,000
2021-12-27 Kaplan Myron Director Gift −20,000 155,034
2021-12-27 Kaplan Myron Director Gift −5,000 150,034
2021-12-27 Kaplan Myron Director Gift −5,000 145,034

Page 10 of 16 · 301 trades